Evidence map›Paper›PMID 38827981›Full record

ArticleJCPP advances2024

Substance use-related problems in mild intellectual disability: A Swedish nationwide population-based cohort study with sibling comparison.

Andreas Påhlsson-Notini, Shengxin Liu, Magnus Tideman, Antti Latvala, Eva Serlachius, Henrik Larsson, Tatja Hirvikoski, Mark J Taylor, Ralf Kuja-Halkola, Paul Lichtenstein and 1 more

Abstract read
In one paragraph

Article in JCPP advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andreas Påhlsson-NotiniDepartment of Medical Epidemiology and Biostatistics Karolinska Institutet Solna Sweden.ORCID https://orcid.org/0000-0002-8418-1827
Shengxin LiuDepartment of Medical Epidemiology and Biostatistics Karolinska Institutet Solna Sweden.
Magnus TidemanSchool of Health and Social Science Halmstad University Halmstad Sweden.
Antti LatvalaDepartment of Medical Epidemiology and Biostatistics Karolinska Institutet Solna Sweden.
Eva SerlachiusDepartment of Clinical Neuroscience Centre for Psychiatry Research Karolinska Institutet Stockholm Stockholm Sweden.
Henrik LarssonDepartment of Medical Epidemiology and Biostatistics Karolinska Institutet Solna Sweden.
Tatja HirvikoskiDepartment of Women's and Children's Health Pediatric Neuropsychiatry Unit Center for Neurodevelopmental Disorders at Karolinska Institutet Karolinska Institutet Stockholm Sweden.
Mark J TaylorDepartment of Medical Epidemiology and Biostatistics Karolinska Institutet Solna Sweden.ORCID https://orcid.org/0000-0001-5161-4182
Ralf Kuja-HalkolaDepartment of Medical Epidemiology and Biostatistics Karolinska Institutet Solna Sweden.
Paul LichtensteinDepartment of Medical Epidemiology and Biostatistics Karolinska Institutet Solna Sweden.
Agnieszka ButwickaDepartment of Medical Epidemiology and Biostatistics Karolinska Institutet Solna Sweden.ORCID https://orcid.org/0000-0002-7247-2141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evidence for substance use-related problems in individuals with mild intellectual disability is sparse and mainly limited to selected psychiatric populations. We evaluated the risk of substance use-related problems in individuals with mild intellectual disability compared to the general population. Additionally, we have performed secondary sibling comparison analyses to account for familial confounding. Methods: We conducted a population-based cohort study of individuals born in Sweden between 1973 and 2003. A total of 18,307 individuals with mild intellectual disability were compared to 915,350 reference individuals from the general population and 18,996 full siblings of individuals with mild intellectual disability. Information on mild intellectual disability and substance use-related problems was obtained from several Swedish national and regional school and healthcare registers. Substance use-related problems were measured via corresponding diagnostic and legal codes and included alcohol use disorder, drug use disorder, alcohol-related somatic disease, conviction for a substance-related crime, and substance-related death. Results: Individuals with mild intellectual disability had a higher risk of any substance use-related problem compared to the general population (HR, 1.81; 95% CI, 1.72-1.91), both in males (HR, 1.76; 95% CI, 1.65-1.89) and females (HR, 1.89; 95% CI, 1.74-2.05). The risks of substance use-related problems were particularly elevated among individuals with mild intellectual disability and psychiatric comorbidities (HR, 2.21-8.24). The associations were attenuated in the sibling comparison models. Conclusions: Individuals with mild intellectual disability, especially those with psychiatric comorbidity, are at an elevated risk of substance use-related problems. Familial factors shared by full siblings contribute considerably to the association between mild intellectual disability and substance use-related problems.

Indexed as

alcohol abusecriminalitydrug abuseintellectual disabilitysubstance use

Identifiers

PMID38827981
PMCPMC11143951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.